Osteoclasts in osteoradionecrosis: Pathogenic mechanisms and emerging therapies

IF 3.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Bone Pub Date : 2025-08-05 DOI:10.1016/j.bone.2025.117605
Feng Li , Xinyuan Liu , Anne-Laure Vandevelde , Yao Gao , Jeroen Van Dessel , Yi Sun , Robin Willaert
{"title":"Osteoclasts in osteoradionecrosis: Pathogenic mechanisms and emerging therapies","authors":"Feng Li ,&nbsp;Xinyuan Liu ,&nbsp;Anne-Laure Vandevelde ,&nbsp;Yao Gao ,&nbsp;Jeroen Van Dessel ,&nbsp;Yi Sun ,&nbsp;Robin Willaert","doi":"10.1016/j.bone.2025.117605","DOIUrl":null,"url":null,"abstract":"<div><div>Osteoradionecrosis (ORN) is a severe complication of radiation therapy characterized by impaired bone repair and regeneration, disrupting the delicate balance between osteoclast-mediated bone resorption and osteoblast-driven bone formation. Despite significant research, the intricate pathological mechanisms underlying ORN remain incompletely understood. Notably, while radiation therapy generally inhibits the function of most cells in bone tissue, its specific activation of osteoclasts is a key feature of ORN. Recent findings emphasize the pivotal role of excessive osteoclast activity in driving ORN progression.</div><div>This review provides a comprehensive exploration of osteoclast adaptations within the unique bone microenvironment of ORN, shaped by hypoxia, immune dysfunction, and bacterial infections. It delves into the cellular stress responses—including oxidative stress, metabolic reprogramming, autophagy, and iron regulation—that further influence osteoclast function in ORN. By integrating these insights, we evaluate current therapeutic approaches and propose innovative osteoclast-targeted strategies to mitigate ORN. Through this synthesis of emerging evidence, the review sheds light on the complex interplay of factors contributing to ORN pathogenesis and highlights promising avenues for prevention and treatment, offering hope for improved clinical outcomes.</div></div>","PeriodicalId":9301,"journal":{"name":"Bone","volume":"200 ","pages":"Article 117605"},"PeriodicalIF":3.6000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S8756328225002170","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Osteoradionecrosis (ORN) is a severe complication of radiation therapy characterized by impaired bone repair and regeneration, disrupting the delicate balance between osteoclast-mediated bone resorption and osteoblast-driven bone formation. Despite significant research, the intricate pathological mechanisms underlying ORN remain incompletely understood. Notably, while radiation therapy generally inhibits the function of most cells in bone tissue, its specific activation of osteoclasts is a key feature of ORN. Recent findings emphasize the pivotal role of excessive osteoclast activity in driving ORN progression.
This review provides a comprehensive exploration of osteoclast adaptations within the unique bone microenvironment of ORN, shaped by hypoxia, immune dysfunction, and bacterial infections. It delves into the cellular stress responses—including oxidative stress, metabolic reprogramming, autophagy, and iron regulation—that further influence osteoclast function in ORN. By integrating these insights, we evaluate current therapeutic approaches and propose innovative osteoclast-targeted strategies to mitigate ORN. Through this synthesis of emerging evidence, the review sheds light on the complex interplay of factors contributing to ORN pathogenesis and highlights promising avenues for prevention and treatment, offering hope for improved clinical outcomes.

Abstract Image

放射性骨坏死中的破骨细胞:致病机制和新兴疗法。
骨放射性坏死(osteradionecrosis, ORN)是放射治疗的严重并发症,其特征是骨修复和再生受损,破坏破骨细胞介导的骨吸收和成骨细胞驱动的骨形成之间的微妙平衡。尽管进行了大量的研究,但ORN背后复杂的病理机制仍然不完全清楚。值得注意的是,虽然放射治疗通常会抑制骨组织中大多数细胞的功能,但其对破骨细胞的特异性激活是ORN的一个关键特征。最近的研究结果强调了过度破骨细胞活性在驱动ORN进展中的关键作用。这篇综述全面探讨了破骨细胞在缺氧、免疫功能障碍和细菌感染形成的ORN独特骨微环境中的适应性。它深入研究了细胞应激反应-包括氧化应激,代谢重编程,自噬和铁调节-进一步影响ORN的破骨细胞功能。通过整合这些见解,我们评估了当前的治疗方法,并提出了创新的破骨细胞靶向策略来缓解ORN。通过对新出现的证据的综合,该综述揭示了导致ORN发病机制的因素之间复杂的相互作用,并强调了预防和治疗的有希望的途径,为改善临床结果提供了希望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone
Bone 医学-内分泌学与代谢
CiteScore
8.90
自引率
4.90%
发文量
264
审稿时长
30 days
期刊介绍: BONE is an interdisciplinary forum for the rapid publication of original articles and reviews on basic, translational, and clinical aspects of bone and mineral metabolism. The Journal also encourages submissions related to interactions of bone with other organ systems, including cartilage, endocrine, muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and immune systems. Particular attention is placed on the application of experimental studies to clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信